Xcovery and EVERSANA partner for US commmercialisation of lung cancer drug Ensacove

Jazz Pharmaceuticals reports FDA acceptance and Priority Review of sBLA for Ziihera (zanidatamab-hrii) combinations in first-line HER2+ locally advanced or metastatic GEA

Cantargia reports early remission data from nadunolimab trial in MDS and AML

WuXi Biologics announces structural completion and key equipment arrival at Chengdu microbial manufacturing site

HanchorBio chooses Bloomberg to enhance strategic intelligence across drug development and global biopharma

Servier completes Day One Biopharmaceuticals acquisition

Apotex and Cumberland Pharmaceuticals to integrate their US branded businesses

Orion Pharma launches Phase 1b/2 TEADCO trial of ODM-212 in advanced solid tumours

WuXi Biologics gains MFDS approval for three Wuxi manufacturing sites

WuXi Biologics receives South Korean certification for commercial manufacturing of bispecific antibody therapeutics

Labcorp launches FDA-approved companion diagnostic to identify ovarian cancer patients' KEYTRUDA eligibility

PureTech Health reports positive Phase 1b data for LYT-200 in MDS and AML

FDA extends review timeline for Sanofi's Sarclisa subcutaneous formulation in multiple myeloma

Inhibrx provides clinical update on ozekibart (INBRX-109) for colorectal cancer treatment

Lytix reports phase II results showing durable responses in advanced melanoma